FACS

Dissecting cellular behavior

Unraveling the nuanced functions of individual cells remains a critical endeavor. Fluorescence-activated cell sorting (FACS) has emerged as a cornerstone technology in this pursuit, offering unparalleled resolution and precision in dissecting cellular behavior at the single-cell level. At PharmaLegacy, our FACS service leverages this powerful tool to empower you with a multifaceted investigative toolkit, enabling you to delve into the dynamic landscapes of cell surface markers, intracellular signaling pathways, and functional responses. This comprehensive approach serves as a springboard for groundbreaking discoveries across diverse biological disciplines, propelling our understanding of disease mechanisms, immune responses, and therapeutic efficacy to new heights.

Leverage Our FACS Capacities Now
FACS

MODELS / SERVICES

Markers for different cell populations such as TILs analysis, immune profiling of whole blood and organs, antigen binding assay, antigen block assay.

 

 

Cytokines/phospho-proteins detection.

 

Bead-based cytometric bead array (CBA) assay.

Cell cycle, cell apoptosis, ADC endocytosis assay, ADC bystander killing assay, cell proliferation assay, cell differentiation assay.

Cell Apoptosis

 

 

Internalization of ADC by FCS with pH sensitive dye

Committed to quality:

  • FDA part 11 compliant
  • Animal studies strictly follow AAALAC and ILAC guidelines
  • Electronically managed, traceable research data
  • Rigorous adherence to international GLP and QA best practices
  • Clients have real-time remote monitoring of studies

Want your scientific discoveries to become treatments? PharmaLegacy’s the right partner for you.

Contact Us

Providing Better Data For Critical Oncology Pipeline Decisions

To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information.

Download our Integrated In Vitro Oncology Assays brochure and see why over 300 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical oncology pipeline decisions.

    127

    We’re ready when you are.

    Tell us your pharmacology challenges.